Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
SinaCurcumin® Potential treatment - clinical evidence Experimental Antiviral Mar/28/2021 2 0
mAB 1-87 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 2-17 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAb 2-51 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 4-18 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 4-8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAb 4A8 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 5-24 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
mAB 1-68 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/12/2021 2 0
Curcumin Potential treatment - theoretical effect Natural product Antiviral Feb/03/2021 6 0